Foster M C, Morris D L, Legan C, Kapila L, Slack R C
Department of Surgery, City Hospital, Nottingham, England.
J Pediatr Surg. 1987 Sep;22(9):869-72. doi: 10.1016/s0022-3468(87)80658-9.
Sulbactam is a beta-lactamase inhibitor, which when administered with ampicillin, increases the latter agents antibacterial activity against beta-lactamase producing organisms. One hundred children between the ages of 5 and 14 undergoing emergency appendectomy were entered into a prospective randomized trial comparing sulbactam and ampicillin (SA) with metronidazole and cefotaxime (MC) as prophylaxis against postoperative wound infection. Patients in whom the appendix was perforated or gangrenous received a 72-hour course of antibiotics, others received a single dose only. The overall wound infection rate was 8% (14% in patients with perforation or gangrene and 4% in those without). There was no difference in infection rate between the two antibiotic groups; there were three wound infections and one subphrenic abscess in patients receiving SA and four wound infections in patients receiving MC. SA, therefore, appears to be a suitable antibiotic combination for use as prophylaxis in appendicitis in children.
舒巴坦是一种β-内酰胺酶抑制剂,与氨苄西林联合使用时,可增强后者对产生β-内酰胺酶的微生物的抗菌活性。100名年龄在5至14岁之间接受急诊阑尾切除术的儿童被纳入一项前瞻性随机试验,比较舒巴坦和氨苄西林(SA)与甲硝唑和头孢噻肟(MC)预防术后伤口感染的效果。阑尾穿孔或坏疽的患者接受72小时疗程的抗生素治疗,其他患者仅接受单剂量治疗。总体伤口感染率为8%(穿孔或坏疽患者为14%,无穿孔或坏疽患者为4%)。两组抗生素的感染率没有差异;接受SA治疗的患者中有3例伤口感染和1例膈下脓肿,接受MC治疗的患者中有4例伤口感染。因此,SA似乎是一种适用于儿童阑尾炎预防的抗生素组合。